Literature DB >> 18495389

Preparation of esomeprazole zinc solid dispersion and study on its pharmacokinetics.

Yongmei Xie1, Ping Xie, Xin Song, Xiaohai Tang, Hang Song.   

Abstract

Esomeprazole zinc (EZ) is a poorly water-soluble substance. In order to increase its dissolution rate and bioavailability, solid dispersions of esomeprazole zinc (SDEZ) in polyethylene glycol 4000 (PEG4000) with different EZ to PEG4000 ratios were prepared by solvent method. Our studies showed that dissolution rate of EZ were distinctively increased in the solid dispersion system compared to that in pure EZ or physical mixtures. The increase of dissolution rate was obviously related to the ratio of EZ to PEG4000. The solid dispersion system (EZ/PEG4000=1/8, w/w) gave the highest dissolution rate: about 14.7-fold higher than that of the pure EZ. EZ was proved to be in amorphous state in this solid dispersion by using differential scanning calorimetry (DSC) and scanning electron microscopy (SEM) techniques. In vivo administration studies, SDEZ in enteric capsule (SDEZ-EC) has a lower Cmax and a longer Tmax than that of esomeprazole magnesium enteric-coated tablet (Nexium), and the differences of Cmax and Tmax between SDEZ-EC and Nexium are significant. This result suggests SDEZ-EC has a lower absorption rate than Nexium and corresponds with the in vitro dissolution.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18495389     DOI: 10.1016/j.ijpharm.2008.04.015

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  4 in total

Review 1.  Controlled release systems containing solid dispersions: strategies and mechanisms.

Authors:  Phuong Ha-Lien Tran; Thao Truong-Dinh Tran; Jun Bom Park; Beom-Jin Lee
Journal:  Pharm Res       Date:  2011-05-07       Impact factor: 4.200

2.  Formulation and evaluation of extended-release solid dispersion of metformin hydrochloride.

Authors:  Sa Patil; Bs Kuchekar; Ar Chabukswar; Sc Jagdale
Journal:  J Young Pharm       Date:  2010-04

3.  Preparation and Characterization of Metformin Hydrochloride - Compritol 888 ATO Solid Dispersion.

Authors:  Sc Jagdale; Sa Patil; Bs Kuchekar; Ar Chabukswar
Journal:  J Young Pharm       Date:  2011-07

4.  In-Vitro Characterization and Oral Bioavailability of Organic Solvent-free Solid Dispersions Containing Telmisartan.

Authors:  Yue Cao; Li-Li Shi; Qing-Ri Cao; Mingshi Yang; Jing-Hao Cui
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.